Search Results

K858 50mg  | ≥99%

CSNpharm

K858 is a selective and ATP-uncompetitive mitotic kinesin Eg5 inhibitor with IC50 value of 1.3 μM.

More Information Supplier Page

K858 10mg  | ≥99%

CSNpharm

K858 is a selective and ATP-uncompetitive mitotic kinesin Eg5 inhibitor with IC50 value of 1.3 μM.

More Information Supplier Page

K858 5mg  | ≥99%

CSNpharm

K858 is a selective and ATP-uncompetitive mitotic kinesin Eg5 inhibitor with IC50 value of 1.3 μM.

More Information Supplier Page

Pramiracetam 5mg  | ≥99%

CSNpharm

Pramiracetam is a nootropic drug derived from piracetam, and is more potent. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries.

More Information Supplier Page

LDN-57444 50mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

LDN-57444 5mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

LDN-57444 10mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

LDN-57444 100mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

Pramiracetam 25mg  | ≥99%

CSNpharm

Pramiracetam is a nootropic drug derived from piracetam, and is more potent. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries.

More Information Supplier Page

Pramiracetam 50mg  | ≥99%

CSNpharm

Pramiracetam is a nootropic drug derived from piracetam, and is more potent. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries.

More Information Supplier Page